Text Size
5 studies found for:    17544766 [PUBMED-IDS]

Modify this search | How to Use Search Results

Show Display Options
Rank Status Study
1 Completed
Has Results 		Dose-Ranging Study of Quadrivalent Human Papillomavirus (HPV) (Types 6,11,16,18) L1 Virus-Like Particle (VLP) Vaccine (V501-007)(COMPLETED)
Conditions: Papillomavirus Infections;   Genital Diseases, Female
Interventions: Biological: Quadrivalent HPV (Types 6,11,16,18) L1 VLP Vaccine 20/40/40/20;   Biological: Quadrivalent HPV (Types 6,11,16,18) L1 VLP Vaccine 40/40/40/40;   Biological: Quadrivalent HPV (Types 6,11,16,18) L1 VLP Vaccine 80/80/40/80;   Biological: Placebo (mcg) (Aluminum Adjuvant)225;   Biological: Placebo (mcg) (Aluminum Adjuvant) 450
2 Completed
Has Results 		Cervical Intraepithelial Neoplasm (CIN)-Warts Efficacy Trial in Women (Gardasil)
Conditions: Cervical Cancer;   Genital Warts
Interventions: Biological: V501;   Biological: Comparator: Placebo;   Biological: Human Papillomavirus (HPV) 16 Monovalent
3 Active, not recruiting
Has Results 		Cervical Intraepithelial Neoplasm (CIN) in Women (Gardasil)(V501-015 AM5; EXT1; EXT2(AM1))
Conditions: Cervical Cancer;   Genital Warts
Interventions: Biological: Gardasil, human papillomavirus (type 6, 11, 16, 18) recombinant vaccine;   Biological: Matching Placebo
4 Completed
Has Results 		Study of Human Papillomavirus (HPV) 16 Vaccine in the Prevention of HPV 16 Infection in 16- to 23-Year-Old Females
Condition: HPV 16 Infection
Interventions: Biological: Comparator: HPV 16 L1 Vaccine;   Biological: Comparator: Placebo
5 Recruiting Multicenter Trial Evaluating the Immunogenicity of HPV Vaccination in Girls on Immunosuppressive Therapy.
Conditions: Transplantation;   Systemic Lupus Erythematosus;   Systemic Immune Disease
Intervention: Biological: HPV prophylactic vaccine Gardasil
To Top

† Indicates status has not been verified in more than two years